Page last updated: 2024-10-29

iohexol and Cardiomyopathy, Congestive

iohexol has been researched along with Cardiomyopathy, Congestive in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsai, IC1
Lee, T1
Tsai, WL1
Chen, MC1
Wu, MJ1
Lee, WL1
Ting, HJ1
Ring, ME1
Kern, MJ1
Genovely, H1
Serota, H1
Vandormael, M1

Trials

1 trial available for iohexol and Cardiomyopathy, Congestive

ArticleYear
Contrast enhancement in cardiac MDCT: comparison of iodixanol 320 versus iohexol 350.
    AJR. American journal of roentgenology, 2008, Volume: 190, Issue:1

    Topics: Cardiomyopathy, Dilated; Contrast Media; Coronary Angiography; Coronary Stenosis; Female; Heart; Hea

2008

Other Studies

1 other study available for iohexol and Cardiomyopathy, Congestive

ArticleYear
Attenuation of pulsus alternans during coronary angiography.
    Catheterization and cardiovascular diagnosis, 1990, Volume: 20, Issue:3

    Topics: Angiography; Cardiomyopathy, Dilated; Coronary Angiography; Female; Humans; Iohexol; Middle Aged; Pu

1990